Market Overview:
The global Foot and Mouth Disease (FMD) vaccine market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of Foot and Mouth Disease (FMD) across the globe, rising demand for emergency vaccines, and technological advancements in vaccine development. The conventional vaccines segment is expected to dominate the global Foot and Mouth Disease (FMD) vaccine market during the forecast period. This segment is projected to account for more than 60% share of the total market by 2030. The growth in this segment can be attributed to factors such as rising awareness about preventive measures against Foot and Mouth Disease (FMD), increasing number of outbreaks due to FMD, and growing investments by key players in research & development activities for new conventional vaccines.
 Vaccine Industry Outlook.svg)
Product Definition:
A Foot and Mouth Disease (FMD) vaccine is a vaccine that helps to protect animals against Foot and Mouth Disease (FMD), a viral disease that affects cattle, pigs, goats, sheep, deer, and other animals. The Foot and Mouth Disease (FMD) vaccine is important because it can help to prevent the spread of the virus and help to protect animals from becoming infected.
Conventional Vaccines:
Conventional vaccines are those used to prevent diseases against which a vaccine is available. The prevention of diseases by using conventional vaccines does not mean that the disease cannot occur in vaccinated individuals. It simply means that, with proper immunization, the chances of being infected with a particular disease are less as compared to non-vaccinated individuals.
Emergency Vaccines:
Emergency vaccines are used to immunize animals against a disease or infection. They are also known as emergency therapeutic vaccines or prophylactic (preventive) vaccines. These products act in very less time and hence help in preventing the spread of an epidemic before it occurs.
Application Insights:
The other application segment includes feed and food animal industry. The conventional vaccines are used for foot and mouth disease in animals, including cattle, swine, sheep and dogs. On the other hand, emergency vaccines are intended for use in emergencies that may arise due to FMD such as mass vaccination of animals or humans.
Clinic was the largest application segment with a revenue share of over 40% in 2017 owing to high usage rates of FMD vaccine among veterinarians at clinics worldwide. Conventional veterinary clinics administer regular services along with farm-based emergency services that cover large areas rapidly resulting in saving time and resources required for isolation procedures during an outbreak of FMD virus infection.
Regional Analysis:
Europe dominated the global market in 2017, with a revenue share of over 40.0%. The region is expected to maintain its dominance throughout the forecast period on account of high R&D investments and presence of key manufacturers. In addition, favorable government initiatives for FMD vaccine development are anticipated to propel industry growth in this region.
Asia Pacific is projected to witness lucrative growth during the forecast period owing to rising awareness about FMD vaccination among livestock owners and increasing investment by governments & private players for manufacturing these vaccines at low cost. Furthermore, growing trade activities between countries prone to outbreaks and those unaffected by it are expected drive demand further across this region over the next eight years (2030).
Growth Factors:
- Increasing awareness about Foot and Mouth Disease (FMD) and its prevention among people, especially in developing countries.
- Rising demand for Foot and Mouth Disease (FMD) vaccines from the livestock industry due to increasing outbreaks of the disease.
- Growing number of collaborations between vaccine manufacturers and research institutes for development of new Foot and Mouth Disease (FMD) vaccines.
- Technological advancements in vaccine production that are resulting in more efficient and affordable vaccines against Foot and Mouth Disease (FMD).
Scope Of The Report
Report Attributes
Report Details
Report Title
Foot and Mouth Disease (FMD) Vaccine Market Research Report
By Type
Conventional Vaccines, Emergency Vaccines
By Application
Hospital, Clinic, Other
By Companies
Agrovet market, Biogenesis Bago, Vecol, FGBI - Federal Centre for Animal Health, Indian Immunologicals, Merial, VSVRI, FMD Center, Limor de Colombia, Agrovet market
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Foot and Mouth Disease (FMD) Vaccine Market Report Segments:
The global Foot and Mouth Disease (FMD) Vaccine market is segmented on the basis of:
Types
Conventional Vaccines, Emergency Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agrovet market
- Biogenesis Bago
- Vecol
- FGBI - Federal Centre for Animal Health
- Indian Immunologicals
- Merial
- VSVRI
- FMD Center
- Limor de Colombia
- Agrovet market
 Vaccine Market Overview.svg)
Highlights of The Foot and Mouth Disease (FMD) Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Conventional Vaccines
- Emergency Vaccines
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Foot and Mouth Disease (FMD) Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Vaccine Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Foot and Mouth Disease (FMD) Vaccine is a vaccine that helps protect people from getting Foot and Mouth Disease. It is made up of pieces of the Foot and Mouth Disease virus.
Some of the key players operating in the foot and mouth disease (fmd) vaccine market are Agrovet market, Biogenesis Bago, Vecol, FGBI - Federal Centre for Animal Health, Indian Immunologicals, Merial, VSVRI, FMD Center, Limor de Colombia, Agrovet market.
The foot and mouth disease (fmd) vaccine market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Foot and Mouth Disease (FMD) Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Foot and Mouth Disease (FMD) Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Foot and Mouth Disease (FMD) Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Foot and Mouth Disease (FMD) Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Foot and Mouth Disease (FMD) Vaccine Market Size & Forecast, 2020-2028
4.5.1 Foot and Mouth Disease (FMD) Vaccine Market Size and Y-o-Y Growth
4.5.2 Foot and Mouth Disease (FMD) Vaccine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Conventional Vaccines
5.2.2 Emergency Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Foot and Mouth Disease (FMD) Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Conventional Vaccines
9.6.2 Emergency Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Conventional Vaccines
10.6.2 Emergency Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Conventional Vaccines
11.6.2 Emergency Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Conventional Vaccines
12.6.2 Emergency Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Conventional Vaccines
13.6.2 Emergency Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Foot and Mouth Disease (FMD) Vaccine Market: Competitive Dashboard
14.2 Global Foot and Mouth Disease (FMD) Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Agrovet market
14.3.2 Biogenesis Bago
14.3.3 Vecol
14.3.4 FGBI - Federal Centre for Animal Health
14.3.5 Indian Immunologicals
14.3.6 Merial
14.3.7 VSVRI
14.3.8 FMD Center
14.3.9 Limor de Colombia
14.3.10 Agrovet market
